RAD50 and breast carcinoma: In our study, we report three breast cancer cases (3/205; 1.46%) with (1) two VUSs in BRCA2 and ATM genes; (2) one pathogenic variant in the BRCA2 gene and one VUS in the RAD50 gene; (3) two pathogenic variant in BRCA1 gene.